dazoxiben has been researched along with pituitrin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Garis, RM; Dusting, GJ; Li, DM | 1 |
| Fulton, CT; Stallone, JN | 1 |
| Kuo, L; Li, M; Stallone, JN | 1 |
3 other study(ies) available for dazoxiben and pituitrin
| Article | Year |
|---|---|
Inhibition of vasoconstrictor mechanisms by dazoxiben in the rat mesenteric vasculature.
Topics: Animals; Cyclooxygenase Inhibitors; Electric Stimulation; Imidazoles; Indomethacin; Male; Norepinephrine; Oxidoreductases; Prazosin; Prostaglandins; Rats; Rats, Inbred Strains; Splanchnic Circulation; Sympathetic Nervous System; Thromboxane-A Synthase; Vasoconstriction; Vasopressins | 1985 |
Sexual dimorphism in prostanoid-potentiated vascular contraction: roles of endothelium and ovarian steroids.
Topics: Animals; Aorta; Bridged Bicyclo Compounds, Heterocyclic; Cyclooxygenase Inhibitors; Endothelium, Vascular; Enzyme Inhibitors; Estrogens; Fatty Acids, Unsaturated; Female; Hydrazines; Imidazoles; Indomethacin; Male; Ovariectomy; Phenylephrine; Progesterone; Prostaglandins; Rats; Rats, Sprague-Dawley; Sex Characteristics; Thromboxanes; Vasoconstriction; Vasoconstrictor Agents; Vasopressins | 2002 |
Estrogen potentiates constrictor prostanoid function in female rat aorta by upregulation of cyclooxygenase-2 and thromboxane pathway expression.
Topics: Animals; Aorta, Thoracic; Cyclooxygenase 1; Cyclooxygenase 2; Drug Implants; Endothelium, Vascular; Enzyme Induction; Enzyme Inhibitors; Epoprostenol; Estradiol; Female; Imidazoles; Immunohistochemistry; Male; Membrane Proteins; Muscle, Smooth, Vascular; Ovariectomy; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptors, Thromboxane; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Thromboxane A2; Thromboxane-A Synthase; Up-Regulation; Vasoconstriction; Vasopressins | 2008 |